导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -1.73% | 2728/4773 |
| 近一周 | -2.05% | 1126/5462 |
| 近一月 | -3.98% | 2124/5421 |
| 近一季 | -7.32% | 2362/5209 |
| 近半年 | -3.79% | 2322/4920 |
| 近一年 | -0.20% | 2686/4366 |
| 近两年 | 43.45% | 1716/2954 |
| 近三年 | 23.75% | 1332/2253 |
| 成立以来 | 74.22% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.83% 2926/4961 |
11.76% 2298/5312 |
- - |
- - |
| 2025 | 19.12% 2249/4813 |
-0.87% 2440/3635 |
1.79% 2137/4076 |
18.24% 2325/4524 |
-0.16% 2389/4813 |
| 2024 | 13.31% 1154/3463 |
1.99% 835/2808 |
-1.72% 1100/3014 |
16.12% 1531/3129 |
-2.65% 2151/3463 |
| 2023 | -11.05% 1365/2656 |
3.50% 1180/2280 |
-5.00% 1338/2385 |
-3.54% 949/2515 |
-6.21% 1671/2655 |
| 2022 | -20.29% 959/2207 |
-14.50% 954/1919 |
6.98% 559/2016 |
-13.04% 825/2113 |
0.21% 1524/2208 |
| 2021 | 1.26% 682/1822 |
-2.63% 683/1255 |
7.93% 660/1330 |
-5.47% 811/1466 |
1.93% 746/1822 |
| 2020 | 35.55% 409/1250 |
-6.19% 465/1028 |
15.47% 498/1067 |
10.58% 533/1164 |
13.16% 385/1184 |
| 2019 | 31.26% 473/1092 |
25.13% 478/754 |
-3.68% 406/804 |
4.77% 183/850 |
3.94% 822/918 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 前海开源MSCI中国A股指数A VS. 长安沪深300非周期A(740101) |